Align Technology, Inc. v. International Trade Commission

771 F.3d 1317, 575 Fed. Appx. 899, 111 U.S.P.Q. 2d (BNA) 1855, 36 I.T.R.D. (BNA) 713, 2014 U.S. App. LEXIS 24702, 2014 WL 3537066
CourtCourt of Appeals for the Federal Circuit
DecidedJuly 18, 2014
Docket2013-1240, 2013-1363
StatusPublished
Cited by2 cases

This text of 771 F.3d 1317 (Align Technology, Inc. v. International Trade Commission) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Align Technology, Inc. v. International Trade Commission, 771 F.3d 1317, 575 Fed. Appx. 899, 111 U.S.P.Q. 2d (BNA) 1855, 36 I.T.R.D. (BNA) 713, 2014 U.S. App. LEXIS 24702, 2014 WL 3537066 (Fed. Cir. 2014).

Opinion

CHEN, Circuit Judge.

The International Trade Commission’s regulations authorize the Commission to review a decision of an administrative law judge (ALJ) when that decision is designated as an “initial determination.” Other ALJ decisions, such as an “order,” are not reviewable. Here, the ALJ denied a motion via an order. This case requires us to consider whether the Commission’s review of that order was procedurally sound. For the reasons set forth below, we hold that it was not.

I. BACKGROUND

This case arises out of a proceeding before the Commission to enforce a Consent Order entered into by Align Technology, Inc. (Align), the complainant of an original, underlying investigation, and respondents to that investigation, Ortho-Clear, Inc., OrthoClear Holdings, Inc., and OrthoClear Pakistan Pvt, Ltd. (collectively, OrthoClear).

Align develops, manufactures, and markets clear aligners to treat malocclusion— i.e., teeth misalignment. Conventionally, dental professionals treated misalignment with metal archwires and brackets, commonly known as braces. Braces, however, have a number of disadvantages, including tooth discoloration, oral discomfort, and, for some, embarrassment.

*1319 To overcome these problems, Align conceived of and developed its clear aligners, marketed as the Invisalign System. The Invisalign System, which is based on Align’s patented technology, uses a series of clear dental aligners — “incremental positioning adjustment appliances” — that are worn sequentially over a fixed time period to adjust the position of a patient’s teeth. Because each patient’s teeth are unique, the aligners must be custom-designed. To design these aligners, dental professionals generate and obtain data to determine the positioning of a patient’s teeth and create complex three-dimensional digital models of each incremental configuration for each aligner. The three-dimensional digital model of each configuration is manipulated to create a “digital data set,” which is used to manufacture a series of successive aligners to be worn by a patient that incrementally move the teeth to the desired alignment. In general, Align’s asserted patents are directed to various methods and orthodontic treatment plans using these digital data sets.

In 2005, Align’s founder and former Chief Executive Officer, Muhammad Chisti, founded OrthoClear and used former Align employees in Pakistan and the United States to manufacture and sell dental aligners. Believing OrthoClear to be infringing its patents and using its trade secrets, Align filed a complaint with the Commission in 2006 (hereinafter, the underlying investigation).

A. The Underlying Investigation

Align’s complaint alleged that Ortho-Clear violated 19 U.S.C. § 1337 by importing, selling for importation, or selling ■within the United States after importation aligners that infringe Align’s asserted patents, 1 and also by misappropriating Align’s trade secrets. Notice of Investigation, 71 Fed.Reg. 7995, 7995-96 (Feb. 15, 2006).

In August 2006, OrthoClear negotiated a global settlement with Align that required OrthoClear to assign its entire intellectual property portfolio to Align, to agree to entry of the Consent Order, and to file a joint motion to terminate the investigation. The ALJ granted the joint motion, and the Commission entered the Consent Order and terminated the underlying investigation. See Certain Incremental Dental Positioning Adjustment Appliances and Methods of Producing Same, Inv. No. 337-TA-562, 2006 WL 3462199 (U.S.I.T.C. Nov. 13, 2006).

The Consent Order provided, in relevant part:

The incremental dental positioning adjustment appliances manufactured by or for OrthoClear referenced in the complaint and any other articles manufactured in violation of the patents or trade secrets described therein (the “Articles”) are hereby prohibited from importation into the United States until the expiration of the last to expire of the following patents ... U.S. Patent No. 6,722,880 (“the '880 patent”) [and] U.S. Patent No. 6,471,511 (“the '511 patent”) ..., except under license of the patent owner or as provided by law.

J.A. 69; id. at 7974-75 ¶ 2. The Consent Order also included successor and aiding- and-abetting provisions that extended the importation prohibition beyond Ortho-Clear. See J.A. 7675 ¶ 2 (mandating that OrthoClear shall not “knowingly aid, abet, encourage, participate in, or induce the sale for importation into the United States or sale in the United States after importation of the Articles”); id. ¶ 3 (providing that the Consent Order “shall be *1320 applicable and binding upon OrthoClear, its officers, directors, agents, servants, employees, successors and assigns, and all persons, firms, or corporations acting or claiming to act on its behalf or under its direction or authority”).

B. The Enforcement Proceeding

After suspecting that OrthoClear and others were violating the Consent Order, Align filed a new complaint, this time for an enforcement proceeding under 19 C.F.R. § 210.75 (hereinafter, the enforcement proceeding). 2 The Commission then instituted an investigation against six respondents (hereinafter, Intervenors): ClearCorrect Operating, LLC (hereinafter, ClearCorrect USA), ClearCorrect Pakistan (Private), Ltd. (hereinafter, ClearCorrect Pakistan), Mudassar Rathore, Waqas Wahab, Nadeem Arif, and Asim Waheed. 77 Fed.Reg. 25747 (May 1, 2012).

ClearCorrect USA is the successor of ClearCorrect Systems, ■ LLC — a company formed by one of OrthoClear’s customers shortly after OrthoClear ceased its operations and transferred its intellectual property and customers’ patients to Align. The new complaint alleged that ClearCor-rect USA works with ClearCorrect Pakistan to provide infringing dental aligners: specifically, that ClearCorrect Pakistan creates in Pakistan the digital data sets used to create the molds on which the aligners are formed, while ClearCorrect USA manufactures and sells aligners in the United States. The complaint also alleged that ClearCorrect Pakistan imports the digital data sets by electronic transmission to ClearCorrect USA. J.A. 7699 ¶¶ 94-95. 3

According to Align, Intervenors had violated the Consent Order by importing into the United States, offering for sale, or selling for importation digital data sets used to manufacture dental aligners in the United States, and that those acts (1) used Align’s trade secrets and (2) induced or contributed to the infringement of certain claims of Align’s patents. 4 Id. at 7698-99 ¶¶ 90-91. Align also alleged that Interve-nors should be liable for aiding and abetting the same acts, id. at 7700-01 ¶ 102, and that ClearCorrect USA and ClearCor-rect Pakistan were each a “successor, assign, or agent” of the original OrthoClear respondents, id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Swagway, LLC v. Itc
Federal Circuit, 2019
Swagway, LLC v. Int'l Trade Comm'n
934 F.3d 1332 (Federal Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
771 F.3d 1317, 575 Fed. Appx. 899, 111 U.S.P.Q. 2d (BNA) 1855, 36 I.T.R.D. (BNA) 713, 2014 U.S. App. LEXIS 24702, 2014 WL 3537066, Counsel Stack Legal Research, https://law.counselstack.com/opinion/align-technology-inc-v-international-trade-commission-cafc-2014.